AGO2 and neuroblastoma: We demonstrated that knockdown of HIF-2α or AGO2 prevented the miR-558-facilitated tumorigenesis and aggressiveness of NB cells in vitro and in vivo, suggesting that the miR-558 may exert its oncogenic functions, at least in part, through recruiting AGO2 to facilitate the HIF-2α expression in NB.